Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
15.00
-0.29 (-1.90%)
At close: Jul 8, 2025, 4:00 PM
15.39
+0.39 (2.60%)
After-hours: Jul 8, 2025, 7:25 PM EDT
Crescent Biopharma Employees
The last reported number of employees for Crescent Biopharma was 4.
Employees
4
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
225.65M
No historical employees data available.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CBIO News
- 20 hours ago - Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer - GlobeNewsWire
- 22 days ago - Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million - GlobeNewsWire
- 4 weeks ago - GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals - Business Wire
- 5 weeks ago - Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC - Business Wire
- 2 months ago - Crescent Biopharma Appoints David Lubner to Board of Directors - GlobeNewsWire
- 3 months ago - Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - GlobeNewsWire
- 4 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire